Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
727 dagar sedan
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
994 dagar sedan
European Shares Subdued With Focus On Ongoing Ukraine Talks
European stocks were subdued on Monday while the U.S. dollar wobbled after the Trump-Putin summit ended without a breakthrough on halting the war in Ukraine.
RTTNews
|
18 minuter sedan
Asian Shares Rise As Alaska Talks Show Progress
Asian stocks rose broadly on Monday as investors reacted to ongoing U.S.-Russia talks on Ukraine and looked ahead to upcoming Federal Reserve Jerome Powell's Jackson Hole speech for clues on whether the U.S. central bank will cut interest rates next month.
The summit between U.S. President Donald Trump and Russian President Putin in Alaska yielded no concrete agreements, but Russia agreed to "game-changing" security guarantees for Ukraine, helping inject new momentum into stalled efforts to end the Russia-Ukraine war.
RTTNews
|
42 minuter sedan
Yen Falls Amid Risk-on Mood
The Japanese yen weakened against other major currencies in the Asian session on Monday as Asian stock markets traded higher, amid expectations of the three-year-plus war between Russia and Ukraine ending soon, with U.S. President Donald Trump saying he and Russian President Putin discussed land transfers and security guarantees for Ukraine and had "largely agreed".
RTTNews
|
3h 28minuter sedan
Yen Falls Against Majors
The Japanese yen weakened against other major currencies in the Asian session on Monday.
RTTNews
|
3h 38minuter sedan
European Shares Seen Opening Up On Russia-Ukraine Hopes
European stocks are seen opening a tad higher on Monday as hope prevails for a swift resolution to the Russia-Ukraine conflict.
RTTNews
|
3h 47minuter sedan
Sensex, Nifty Rally As Automakers Surge On Modi's Big GST Reform Push
Indian shares opened on a buoyant note on Monday after S&P Global Ratings upgraded India's sovereign ratings and Prime Minister Narendra Modi promised next generational GST reforms by Diwali, which will bring down the tax burden on consumers as well as MSMEs.
RTTNews
|
4h 59minuter sedan
